Vote now in STAT Madness 2024

Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Click on each matchup for a short summary of each school’s pioneering research. Then pick your favorites. Help us crown a champ!

Previous Winners | Official Rules | FAQ

Vita 34 returns to growth path in 2023 – Biotech Investments

EQS-News: Vita 34 AG / Key word(s): Annual Results Vita 34 returns to growth path in 2023 30.04.2024 / 22:51 CET/CEST The issuer is solely

May 1, 2024

The Supreme Court could overturn the Chevron doctrine. Here’s how that could hurt the FDA

The Supreme Court on Wednesday heard oral arguments in two cases having to do with federal oversight of herring fishing — but the court’s decisions

January 19, 2024

Gilead and Assembly Biosciences to develop antiviral therapies

Gilead will acquire a 29.9% premium stake in Assembly Bio’s outstanding voting shares. Credit: Sundry Photography / Shutterstock.com. Gilead Sciences has entered a 12-year partnership

October 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.